CN Patent

CN106928150A — 丙烯酰胺苯胺衍生物及其药学上的应用

Assigned to Henry Biomedical Technology (shanghai) Co Ltd · Expires 2017-07-07 · 9y expired

What this patent protects

本发明涉及下述通式(I)所示的丙烯酰胺苯胺类化合物或其药学上可接受的盐。该化合物或其药学上可接受的盐主要通过作用于EGFR家族酪蛋白激酶用于临床疾病治疗的用途。

USPTO Abstract

本发明涉及下述通式(I)所示的丙烯酰胺苯胺类化合物或其药学上可接受的盐。该化合物或其药学上可接受的盐主要通过作用于EGFR家族酪蛋白激酶用于临床疾病治疗的用途。

Drugs covered by this patent

Patent Metadata

Patent number: CN106928150A
Jurisdiction: CN
Classification: —
Expires: 2017-07-07
Drug substance claim: No
Drug product claim: No
Assignee: Henry Biomedical Technology (shanghai) Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.